Golden Cross Stocks — Valuation View · Biological Products, (No Diagnostic Substances)

5 stocks match the Golden Cross Stocks screen. Stocks whose 50-day moving average has just crossed above their 200-day — a classic bullish trend signal. Valuation columns. Filtered to Biological Products, (No Diagnostic Substances). Updated 26 h ago

1–5 of 5


GILD	Gilead Sciences	$187.5B	-57.87	6.16	15.85	58.98	2.1%	151.21	+1.09%	186K
CRSP	Crispr Therapeutics Ag	$5.5B	-12.10	407.72	3.13	18.74	—	56.47	-0.79%	71K
NVAX	Novavax Inc	$1.7B	-6.88	1.52	—	8.91	—	10.34	+0.19%	229K
ZURA	Zura Bio Ltd	$563M	-6.57	—	2.86	2.74	—	5.88	+3.52%	81K
LIMN	Liminatus Pharma, Inc.	$248M	-19.84	—	826.62	—	—	3.70	-2.89%	293

Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.